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Abstract
Background: Data on hepatitis B virus (HBV) prevalence are limited in developing countries. There is also limited
information of consistent condom use efficacy for reducing HBV transmission at the population level. The study goal was to
evaluate the prevalence and factors associated with HBV infection in Peru, and the relationship between anti-HBc positivity
and consistent condom use.
Methods and Findings: Data from two different surveys performed in 28 mid-sized Peruvian cities were analyzed.
Participants aged 18–29 years were selected using a multistage cluster sampling. Information was collected through a
validated two-part questionnaire. The first part (face-to-face) concerned demographic data, while the second part (self-
administered using handheld computers) concerned sexual behavior. Hepatitis B core antibody (anti-HBc) was tested in
7,000 blood samples. Prevalences and associations were adjusted for sample strata, primary sampling units and population
weights. Anti-HBc prevalence was 5.0% (95%CI 4.1%–5.9%), with the highest prevalence among jungle cities: 16.3% (95%CI
13.8%–19.1%). In the multivariable analysis, Anti-HBc positivity was directly associated with geographic region (highlands
OR=2.05; 95%CI 1.28–3.27, and jungle OR=4.86; 95%CI 3.05–7.74; compared to coastal region); and inversely associated
with age at sexual debut (OR=0.90; 95%CI 0.85–0.97). Consistent condom use, evaluated in about 40% of participants, was
associated with reduced prevalence (OR=0.34; 95%CI 0.15–0.79) after adjusting for gender, geographic region, education
level, lifetime number of sex partners, age at sexual debut and year of survey.
Conclusion: Residence in highlands or jungle cities is associated with higher anti-HBc prevalences, whereas increasing age
at sexual debut were associated with lower prevalences. Consistent condom use was associated with decreased risk of anti-
HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle
population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.
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Introduction
Globally, approximately400 million people have chronic Hepatitis
B virus (HBV) infection, the cause of more than 500,000 deaths
worldwide annually [1]. The clinical spectrum of chronic HBV
infection ranges from the asymptomatic carrier state to liver failure,
chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma [2].
HBV is transmitted through percutaneous or mucosal exposure
to infectious blood or other body fluids [3]. Blood, semen and
saliva have been found to be infectious [4]. Among adults, HBV
transmission is associated primarily with sexual experience and
injection drug use (IDU) [5].
Highest HBV prevalences occur in people with multiple sex
partners, female and male sex workers, and sexual contacts of
persons with HBV infection [6,7,8,9]. Cross-study comparisons of
HBV prevalences are complicated by the use of different
serological markers. For example, many general population
surveys are based on the prevalence of surface antigen (HBsAg)
[10], whereas studies of high-risk populations including sexually
transmitted diseases (STD) clinic patients, MSM and IDUs have
more often assessed antibody against hepatitis B core (anti-HBc)
and antibody against surface antigen (anti-HBsAg) [7,8,9].
Overall, the presence of HBsAg indicates current acute or chronic
HBV infection, while anti-HBc is a marker of exposure to HBV,
and anti-HBsAg represents antibodies acquired either from
vaccine or natural infection [11].
In developing countries, data on prevalence of HBV infection in
the general population are limited. Some studies have found
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[10]. In Peru, HBsAg seroprevalence has ranged between 0.82%
and 5.2%, depending on the regions and populations evaluated
[12,13]. Recently, as a part of a large community randomized trial
of STD prevention, the Peru PREVEN project, we analyzed sera
from men and women aged 18 to 29 years for HBsAg. The overall
prevalence in this study was 0.28% [14]. This lower prevalence
may be explained by the involvement of only urban participants
aged from 18 to 29 years, as well as the past implementation of
HBV vaccination campaigns, especially in high-risk populations,
which might have had an impact on the population-based
prevalence.
Two previous studies of FSW have found that consistent
condom use might reduce HBV transmission [15,16]. There are
limited data evaluating anti-HBc prevalence and its association
with consistent condom use at the population level. The purpose of
this study was to determine the prevalence of anti-HBc in relation
to demography, risk behaviors and condom use using blood
samples and behavioral data previously collected from random
samples of young adults in 28 Peruvian cities.
Methods
Study setting and design
Data and sera from two different cross-sectional surveys carried
out in mid-sized cities of Peru have been used for this study. The
first survey was performed between September and December
2005, and the second between August and October 2007. In both
surveys, data concerning sexual behavior as well as biological
samples were collected using handheld computers and identical
methodology.
The PREVEN study, a community randomized trial (CRT) of
STD prevention, began in the year 2000, with development and
testing of several strategies for STD prevention in Peruvian cities
with more than 50,000 inhabitants. In the 2005 survey, 20 cities
participated; while in 2007, the survey included 8 additional cities,
including Lima, the capital of Peru. Originally, 600 participants
(300 of each sex) were recruited per city. For this particular
analysis, a random sample of 250 participants per city was
analyzed.
Study population and sampling methodology
The methodology of PREVEN population-based surveys has
been previously described [17,18]. Briefly, a random sample of
men and women between 18 and 29 years was selected using a
multistage cluster sampling. The first step involved a random
sample of 108 clusters of contiguous residential blocks for each
participating city (each block contained 40 households on
average). Second, a census of households in the selected clusters
was conducted by nurses or midwives trained in the sample frame
methodology, in performing the interviews, and in obtaining
biological specimens. They first collected general information
about location and type of housing, number of people living in the
household, including number of people between 18 and 29 years
of age, and length of time residence in the city. Then, a random
sample of 10 households with eligible members was chosen.
Potential participants were male or female, aged 18-29 years,
living in the city for at least 6 months. Finally, in selected
households with one or more eligible person, a participant was
selected based on most recent birthday.
Selected participants were then interviewed by the nurses and
midwives to confirm eligibility, obtain informed consent and
administer the questionnaire. The informed consent was oral to
keep each participant’s information anonymous, and was
approved by the Institutional Review Boards of the University of
Washington and Universidad Peruana Cayetano Heredia. The
interviewer signed the form to document participant’s approval.
This procedure was performed until a target sample size of 300
men and 300 women per city had been recruited.
Demographic and sexual behavior data collection
Data were collected through a previously validated two-part
questionnaire. The first part was administered face-to-face,
eliciting data concerning demographic characteristics, employ-
ment, marital status, knowledge about STDs, and reproductive
health. The second part was self-administered using handheld
computers, and concerned sensitive characteristics of the partic-
ipant’s sexual behavior. Completing both parts took approximate-
ly 30 minutes. The face-to-face interview was conducted in the
absence of third parties and the self-applied questionnaire was
completed out of sight of the interviewer to ensure confidentiality.
Collection and testing of biological samples
After the questionnaire was completed, the interviewer
explained procedures for sample collection. Men were asked to
provide urine while females were asked to provide self-obtained
vaginal swabs. Females unwilling to provide vaginal swabs were
asked to provide urine. Interviewers then collected venous blood
samples from men and women using a vacuum extraction system
(8–10 ml). Samples were transported to the local laboratory within
4 hours of collection. Serum was separated from the blood sample
and then separated again into three 1-ml vials and frozen at
220uC. Cryovials were sent frozen to the Universidad Peruana
Cayetano Heredia laboratory for storage and analysis.
Syphilis diagnosis was based upon positive RPR Nosticon II
(Organon Teknika), with confirmation with Serodia-TPPA
(Fujirebio, Inc). HIV diagnosis was based upon Uni-Form II
Ag/Ab (Biomerieux-Vironostika) ELISA NEW LAV BLOTI
(BIO-RAD) as a confirmatory test. All diagnostic tests were
performed following manufacturers’ procedures.
Antibody against HBc (anti-HBc) was tested by electro-chemo-
luminescence immunoassay to determine in vitro the qualitative
presence of immunoglobulin M and G against HBc in sera using a
ROCHE Elecsys automatic analyzer. All of the process was
performed in accordance with manufacturer’s instructions. The
lower limit of detection for this test is #0.8 Paul Ehrlich Institute
units per ml (U-IPE/ml). Without confirmatory testing, the
reported sensitivity is 100% and the specificity 99.6% [19].
Sample size
During the 2005 survey, information was collected from 14,280
participants, of whom 11,825 (82.8%) provided blood samples and
gave approval for sample storage and use for future studies. In the
2007 survey, data were collected from 5,921 participants, of whom
4,781 (80.7%) provided blood samples and approved sample
storage and use for future studies. Due to budget limitations, 250
samples and their respective questionnaires for each city were
randomly selected from all the blood samples collected in the 2005
and 2007 surveys, yielding a total of 7,000 serum specimens.
Data analysis
Statistical analyses were performed using STATA 11.2 for
Windows (STATA Corporation, College Station, Texas, US).
Prevalences and associations were assessed taking into account
sample strata, primary sampling units and population weights
using SVY methods. Crude results of associations are shown in
Supporting Information S1.
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prevalence was calculated, as well as prevalences according to
geographic regions and risk populations. Potential risk factors
associated with anti-HBc prevalence were calculated using
Pearson’s Chi squared (x
2) test, Fisher’s exact test and t-test for
independent samples according to the variable analyzed. Bivariate
models were obtained using logistic regression analysis. Variables
found to be significant (p,0.10) in bivariate analyses were entered
into a multivariable logistic regression model using a forward
stepwise method to determine odd ratios (OR) and their 95%
confidence intervals (95%CI).
Adjusted odd ratios (aOR) were then calculated using logistic
regression estimates to measure associations between anti-HBc
prevalence and self-reported condom use. The condom use
variable was evaluated using detailed questions concerning the
number of sexual encounters and condom use over the previous
t h r e em o n t h sw i t he a c ho ft h el a st three sex partners. For each
of the last three partners, the respondent was asked ‘‘during the
last three months with that partner, how many times did you
have sexual intercourse?’’, and was then asked ‘‘how many times
did you have sexual encounters without using a condom?’’ In
the analysis, consistent condom use was defined as reported
condom use ‘‘always’’ during the last three months with each of
t h el a s tt h r e es e xp a r t n e r s .I nt h es a m ew a y ,n e v e ru s eo f
condom was defined as ‘‘never’’ using condoms with any of the
last three sex partners, and all other responses were classified as
occasional.
All variables evaluated as potential risk factors were assessed as
potential effect modifiers and/or confounders. Potential effect
modifiers were assessed using logistic regression and likelihood
ratio tests (comparing the model with and without the interaction
term). Potential confounders were considered when the adjusted
risk estimate differed from the crude estimate by 10% or more.
Attributable risk percent (AR%), defined as the likelihood that the
disease in a exposed person was due to exposure, was calculated as
performed in case control studies assuming that RR is very similar
to OR (i.e. rare disease) [20]. Thus, the AR% was calculated based
on the OR of comparing odds of consistent condom users to odds
of those who reported never use condom, according to the
following formula:
Attributableriskpercent~
1
Oddsratio{1
1
Oddsratio
0
@
1
Ax100
Results
Seven thousand participants were included in this analysis. Of
these, 3298 (47.6%) were men. The mean age was 22.9 (SD: 3.5)
years, 57.3% of participants had less than 12 years of education
and 64.2% were never married.
Prevalence of HBV infection
Overall, the prevalence of anti-HBc taking into account samples
strata, primary sampling units and population weights was 5.0%
(95%CI: 4.1% –5.9%). Anti-HBc prevalence was 3.3% (95%CI:
2.2% –4.6%) in coastal cities, 5.9% (95%CI: 4.6%–7.4%) in the
highlands cities, and 16.3% (95%CI: 13.8%–19.1%, p,0.001) in
the jungle cities.
Using information from another assessment of HBsAg preva-
lence in a random sample of the same group of participants [14], a
total of 4,356 participants had both anti-HBc and HBsAg results.
Overall, of 324 anti-HBc positive participants, 15 (4.6%) were also
HBsAg positive.
When prevalence was stratified by risk populations, anti-HBc
prevalence was 10.1% (95%CI 4.4%–21.3%) among 341 men
who reported ever having sex with men compared to 5.7%
(95%CI 4.4%–7.3%) among 2,528 exclusively heterosexual men.
Similarly, adjusted anti-HBc prevalence was 3.3% (95%CI 1.3%–
7.9%) among 112 women reported ever having received money or
other goods for sex compared to 4.4% (95%CI 3.5%–5.7%)
among 2914 women who did not.
Risk factors for HBV infection
Demographic variables associated with anti-HBc positivity
(Table 1) included participant sex (p = 0.009) and geographic
region (p,0.001). Among sexual behaviors, younger age at sexual
debut (p,0.001) was the only variable associated with anti-HBc
positivity after taking into account sample design. The prevalence
of anti-HBc among MSM was highest for those reporting both
insertive and receptive anal sex; however, this trend was not
significant (Table 2).
In the multivariable analysis, anti-HBc positivity was indepen-
dently associated with geographic region (greater risk in highlands
Table 1. Demographic variables associated with HBV
positivity: percentages and p-values account for sample
strata, primary sampling units and population weights.
Variables Anti-HBc positive/Total p-value
Gender
+
Male 242/3298 (6.16%) 0.009
Female 266/3635 (4.13%)
Geographic region
Coastal 118/3250 (3.32%) ,0.001
Highlands 136/2000 (5.87%)
Jungle 258/1750 (16.25%)
Educational level
+
#11 years 329/3885 (5.25%) 0.32
.11 years 161/2894 (4.37%)
Age at interview
+
18–21 years 186/2805 (4.90%) 0.59
22–25 years 164/2226 (5.55%)
26–29 years 158/1897 (4.55%)
Employment
+
Employed 187/2402 (5.24%) 0.66
Unemployed 318/4515 (4.88%)
Income
**, +
No incomes 251/3479 (5.20%) 0.69
1–500 NS 185/2538 (4.59%)
.500 NS 62/800 (5.49%)
Marital status
+
Never married 285/4446 (4.78%) 0.46
Ever married 222/2479 (5.39%)
+Numbers may not add to the total because of missing values.
*Unless stated otherwise: percentages are calculated from row totals.
**NS=Nuevos Soles.
doi:10.1371/journal.pone.0024721.t001
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debut (Table 3).
Self-reported condom use and HBV infection
Among the 2,874 (41.1% of the total) participants who
responded to the questions about condom use, 13.9% reported
consistent use, 42.5% occasional use, and 43.6% never used with
any of the last three partners. Overall, 46.5%, 31.3% and 45.9%
of participants reported never used condom in coastal, highlands
and jungle, respectively. Anti-HBc prevalence was 2.6% among
consistent condom users compared to 4.9% among occasional
users, and 5.8% among never users.
After assessing variables analyzed in the first part of this study,
no effect modifiers were found, whereas gender, geographic region
and age at sexual debut were potential confounders. After
adjusting for aforementioned variables, year of study, as well as
education level and lifetime number of sex partners (confounders
previously described in the literature), condom use was associated
with anti-HBc positivity (adjusted Wald test’s p-value=0.03).
Consequently, risk estimates were: aOR=0.72 (95%CI 0.43–1.21)
for occasional condom users and aOR=0.34 (95%CI 0.15–0.79)
for consistent condom users compared to never users (Table 4).
Crude results and strength of association by geographic region are
shown in Supporting Information S2. When estimates were
calculated by geographic region, association was not significant.
Although direction of the association was the same in the three
sites, significance was not reached due to lack of power (See
Supporting information S3).
Based on these results, it was possible to calculate the
attributable risk percent of consistent condom use: about 66% of
the HBV infected among non-condom users was due to never
using condoms. Similarly, we calculated the attributable risk
percent for occasional condom users: 28%, although adjusted
model shown a non-significant estimate compared to non-users.
Table 2. Sexual behavior and STI variables associated with
HBV positivity: percentages and p-values account for sample
strata, primary sampling units and population weights
+, ++.
Variables Anti-HBc positive/Total p-value
Age at sexual debut
,16 years 171/1589 (8.77%) ,0.001
16–24 years 256/4052 (4.02%)
25–29 years 5/83 (3.57%)
Lifetime number of sex partner
0 60/980 (3.95%) 0.25
1–2 205/3140 (4.57%)
3–4 104/1334 (5.55%)
5 or more 116/1227 (6.57%)
Last year, new sex partners
0 227/3345 (4.79%) 0.17
1 or more 85/1066 (6.60%)
Ever sex with FSW**
No 134/1834 (6.30%) 0.79
Yes 78/1035 (5.81%)
Ever sex with MSM**
No 176/2513 (5.67%) 0.73
Yes, only insertive sex 8/73 (8.34%)
Yes, only receptive sex 3/21 (3.99%)
Yes, both types of sex 7/35 (7.97%)
Received money or other goods for sex (only females)
No 228/2973 (4.43%) 0.53
Yes 4/53 (3.33%)
Syphilis
No 504/6953 (4.98%) 0.22
Yes 8/37 (10.71%)
HIV infection
No 509/6959 (5.02%) 0.57
Yes 3/14 (3.25%)
+Numbers may not add to the total because of missing values.
++Analyses included to those with sexual activity (N=5936) except for lifetime
number of sex partners.
*Unless stated otherwise: percentages are calculated from row totals.
**Only male respondents.
doi:10.1371/journal.pone.0024721.t002
Table 3. Risk factors for HBV infection taking into account
sample strata, primary sampling units and population
weights: bivariate and multivariate model.
Variables
Bivariate
model p-value
Multivariable
model* p-value
OR (95%CI) OR (95%CI)
Gender
Male 1 (Reference) 0.01
Female 0.66 (0.48–0.90)
Geographic region
Coastal 1 (Reference) 1 (Reference)
Highlands 1.82 (1.18–2.79) 0.006 2.05 (1.28–3.27) 0.003
Jungle 5.66 (3.79–8.44) ,0.001 4.86 (3.05–7.74) ,0.001
Age at sexual debut
1
Years (Mean) 0.88 (0.84–0.94) ,0.001 0.90 (0.85–0.97) 0.002
*Stepwise logistic regression analysis, adjusted for all demographic and sexual
behavioral variables significantly associated with anti-HBc positivity in bivariate
analyses (p,0.10).
1Per year of delay of first sexual intercourse.
doi:10.1371/journal.pone.0024721.t003
Table 4. Association between self-reported condom use and
HBV infection taking into account sample strata, primary
sampling units and population weights.
Variables HBV (2) HBV (+) Adjusted Model*
n (%) n (%) OR (95%IC)
Self-reported condom use
Never user 1059 (94.2) 105 (5.8) 1 (Reference)
Occasional user 1248 (95.1) 95 (4.9) 0.72 (0.43–1.21)
Consistent user
1 343 (97.4) 19 (2.6) 0.34 (0.15–0.79)
1Consistent condom users were those who reported condom use ‘‘always’’
during last three months with each of their sexual partners.
*Adjusted for gender, geographic region, education level, lifetime number of
sex partners, age at sexual debut, and year of survey.
doi:10.1371/journal.pone.0024721.t004
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In this report of a large and representative sample, we report
anti-HBc prevalences and sexual factors associated with anti-HBc
positivity. These factors included geographic region and younger
age at sexual debut. We also demonstrated that consistent condom
use is associated with lower anti-HBc prevalences at the
population level.
In a previous study of 1,048 pregnant women between 14 and 19
years in Lima, anti-core prevalence was reported to be 3.5% [21].
Our study, however, reports anti-HBc prevalence among males and
females between 18 and 29 years of age from the generalpopulation
in 28 cities. Similar to other reports [13,22], anti-HBc prevalence
was higher in the jungle than in the highlands and coastal regions.
Overall, the reported prevalence of HBV infection is highest in the
western Amazon area including Brazil and adjacent regions in
Colombia, Peru, and Venezuela [10]. The reason for this finding is
not completely clear; however, participants from jungle cities more
often reported sexual debut ,16 years of age (42.3% for jungle,
19.9% for highlands and 26.2% for coastal cities) and 5 or more
lifetime sex partners (25.6% for jungle, 15.8% for highlands and
16.9% for coastal cities).
Lower age at first sexual intercourse was associated with anti-
HBc positivity. We found that the odds of anti-HBc positivity
increased with younger age at sexual debut, owing to increasing
exposure to cumulative risk (10% of protective effect per year of
delay of first sexual intercourse according to the multivariable
model). Only 4.6% of the participants with anti-HBc positivity also
had HBsAg positive results, in accordance with reports of the
percentage of HBV infected people having chronic disease [4,23].
Interestingly, increasing anti-HBc prevalence was found when the
analysis was performed according to population at sexual risk,
being higher among MSMs than women receiving money or
goods for sex or general population. This result is in line with
STDs trends in Peru [24,25].
In the final multivariable model, variables found in previous
studies to be associated with HBV infection such as educational
level or lifetime number of sex partners were not independently
associated with anti-HBc positivity [21,26,27]. Among those who
reported never having had sexual intercourse, prevalence of anti-
HBc was 4.0%, suggesting that sexual activity is not the only mode
of hepatitis B transmission in this population. Among those
without a sexual history who were anti-HBc positive result, about
75% were between 18 and 21 years indicating early infection,
either through vertical or early horizontal transmission.
Male condoms are an efficient and inexpensive way of reducing
the risk of acquisition of STIs. As has been demonstrated
previously, consistent and correct condom use protects against
bacterial STIs [28], including gonorrhea [29], and chlamydial
infection [30]. Evidence also confirms that consistent condom use
significantly reduces the risk of sexual transmission of HIV [31],
herpes simplex virus [32] and human papillomavirus infections
[33]. However, data on the effectiveness of condoms in reducing
HBV infection have been limited.
In this cross sectional study, we adjusted our crude estimates for
variables found to be associated with both condom use and HBV
infection: gender, geographic region, and age at sexual debut. In
addition, the risk estimate for consistent condom use was significant
after adding to the model other potential confounders previously
described in the literature such as lifetime number of sex partners
and education level [13,21]. In addition, we were able to estimate
the attributable risk percent; but, the OR used for this calculation
may be confounded by unmeasured factors, which might affect the
estimation of the AR%. Two previous studies have reported that
consistent condom use can reduce acquisition of HBV infection
among FSW. The first study of acquisition of HBV infection among
FSWinIndiaused HBsAgasa serological marker. The intervention
group underwent a 6-month program of educational videos, small
group discussions, educational materials, received free condoms,
and it found incidences of 0.04 compared to 0.12 per person-year of
follow-up among intervention and control women, respectively
[15]. The second reported that long-term consistent condom use
had protective effect for anti-HBc positivity among FSW partici-
pating in a control program in Peru [34]. However, two additional
studies carried out in other populations found conflicting results.
The first, a population-based study in India, used a smaller sample
size and found protective effect of condoms only among the female
subgroup [35]. The second, from Brazil, found that non-use of
condoms was highly frequent (57%) among truck drivers but was
not associated with decreased hepatitis B prevalences [36].
Our study has several limitations. First, the questionnaire was
designed in the context of a STD intervention and did not include
information about non-sexual risk factors for HBV. Although
prevalence of intravenous drug use among Peruvians has been
considered negligible [37], we could not evaluate other important
factors such as tattooing, body piercing, blood transfusions,
perinatal transmission, vaccination and household contacts.
Second, our survey was limited to a population of 18 to 29 years
in urban areas. Information regarding other age groups and rural
areas are also essential to understand transmission within the
overall population. Third, because condom use was based on self-
reports, there is the possibility of incorrect recall or social
desirability bias. Our focus on younger adults was in part to
reduce recall bias. Fourth, only 40% of the total sample responded
questions regarding condom use. We compared demographics and
sex-risk variables among those who reported data about condom
and those who did not: only distributions of marital status and
lifetime number of sex partners were different between both
groups (See Supporting Information S4). Thus, inference of results
to the general population might not be completely appropriate.
Further studies are needed to corroborate our results. Finally,
condom use data were based on the participant’s last three
partners during the last three months and sexual experiences
during the past 3 months are not necessarily representative of all
sexual experience, raising the possibility of misclassification.
However, we believe that any misclassification in the condom
use variable would be non-selective with regards to HBV status,
and thus would result in attenuation of the true association; as a
result, the protective effect of condom could be greater than the
association found in this study. The strengths of this study include
the random sampling methodologies, the large population-based
sample, extensive and explicit data on recent sexual behaviors and
sex practices, and the use of computer-assisted self-interview
(CASI) techniques to obtain sensitive data.
In conclusion, anti-HBc prevalences are highest in jungle region
and among men who have sex with men. There are several risk
factors associated with anti-HBc positivity. Consistent condom use
was associated with lower prevalences of anti-HBc. Findings from
this study emphasize the need for primary prevention programs
(vaccination) especially in the jungle population, and imply that
condom use promotion could also be a potential strategy to
prevent infection with HIV and other sexually transmitted
pathogens, but also HBV infection.
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